Microbiome Invest 2018 | Kisaco Research
Novotel London West, London, UK
23 May, 2018
Download Agenda
Speakers
Register

Why Attend

The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space. 

“The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023)” Human Microbiome Market Industry Report – Markets and Markets

100+
Delegates
50:50
Ratio of Academics - Industry
8+
Microbiome Niches Covered
16+
Industry Leading Speakers
4+
Hours of Dedicated Networking

'Pitch Your Microbes' Finalists

Dominik Burziwoda

CEO
Perfood GmbH

Evelina Vågesjö, PhD MBA

CEO
Ilya Pharma

Kristofer Cook

CEO & Co-Founder
Carbiotix

Grégory Lambert

CEO & VP, R&D
TargEDys SA

Mats Wallstrom

CEO
Lavivo

Richard Andrews

CEO
Azitra

Gregory McKenzie, Ph.D.

Vice President of Research and CSO
ConsortiaTX

Dr Soren Krogsgaard Thomsen

CEO
BioMe Oxford

Dr Luis Gosalbez

Director of Business Development
OptiBiotix Ltd

The Speakers

 

Adrian Ferrero

CO-founder and CEO
Biome Makers Inc

Adrian Ferrero

CO-founder and CEO
Biome Makers Inc
 

Andrew Morgan

DuPont Fellow & Chief Scientist
Dupont Nutrition & Health

Andrew Morgan

DuPont Fellow & Chief Scientist
Dupont Nutrition & Health
 

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie Drago

Founder
Gallinee

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin?

Marie’s thesis on the microbiome and the enormous benefits of harnessing helpful bacteria gave her the vision and the know-how to create Gallinée’s formulations. Thanks to her pharmacy background and her beauty experience, Marie designed formulas like no other, and patented the triple biotic complex that you can now find in Gallinée’s products.

 

 

Artem Khlebinkov

Director of Strategist Partnerships
Danone Nutrica Research

Artem Khlebinkov

Director of Strategist Partnerships
Danone Nutrica Research
 

Isabelle De Cremoux

CEO
Seventure Partners

Isabelle De Cremoux

CEO
Seventure Partners
 

David Berry

General Partner
Flagship Ventures

David Berry

General Partner
Flagship Ventures
 

Bram Vanparys

Investment Director
Merck Ventures

Bram Vanparys

Investment Director
Merck Ventures
 

Derek Butler

CEO
MyMicroZoo

Derek Butler

CEO
MyMicroZoo
 

Jim Weston

Vice President and Head of Regulatory Affairs
Seres Therapeutics

Jim Weston

Vice President and Head of Regulatory Affairs
Seres Therapeutics
 

Dr David Cook

Chief Scientific Officer
Seres

David Cook is the Executive Vice President of R&D and Chief Scientific Officer of Seres Therapeutics, Inc. (“Seres”). He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. Prior to joining Seres, he served as the Chief Operating Officer for the International AIDS Vaccine Initiative (IAVI), a global R&D organization. Prior to IAVI, Dr.

Dr David Cook

Chief Scientific Officer
Seres

David Cook is the Executive Vice President of R&D and Chief Scientific Officer of Seres Therapeutics, Inc. (“Seres”). He has over 20 years of experience as a scientist and entrepreneur and has held senior operating and management positions in the biotechnology industry throughout his career. Prior to joining Seres, he served as the Chief Operating Officer for the International AIDS Vaccine Initiative (IAVI), a global R&D organization. Prior to IAVI, Dr. Cook was the founding CEO at Anza Therapeutics, a biotechnology startup that focused on developing a microbial vaccine platform to induce cellular immune responses. Before launching Anza, Dr. Cook held positions of increasing responsibility at the biotechnology corporations Cerus and Eligix, overseeing R&D, program management, manufacturing, and clinical and regulatory affairs. He has led teams in the development and commercialization of several biotech products and has been directly responsible for obtaining marketing authorization from the European Union for four medical products. Dr. Cook is also a co-inventor on more than 25 patents. He earned his undergraduate degree from Harvard College and his Ph.D. in chemistry from the University of California, Berkeley.

 

John Hambour

Director of Research Beyond Borders
Boehringer Ingelheim

John Hambour

Director of Research Beyond Borders
Boehringer Ingelheim
 

Luc Sterkman

CEO
Caelus Health B.V.

Luc Sterkman

CEO
Caelus Health B.V.
 

Mike Romanos

Chief Executive Officer
Microbiotica Ltd.

Dr. Mike Romanos, Ph.D. serves as the Chief Executive Officer at Microbiotica Ltd. He served as the Chief Executive and Executive Director of Crescendo Biologics Limited. Dr. Romanos is employed at Midven Limited. He is Venture Partner of Rainbow Seed Fund. He has more than 20 years' biotech and pharmaceutical industry experience, and within the last 10 years has held international executive positions in GlaxoSmithKline R&D before moving to take leadership of Crescendo Biologics.

Mike Romanos

Chief Executive Officer
Microbiotica Ltd.

Dr. Mike Romanos, Ph.D. serves as the Chief Executive Officer at Microbiotica Ltd. He served as the Chief Executive and Executive Director of Crescendo Biologics Limited. Dr. Romanos is employed at Midven Limited. He is Venture Partner of Rainbow Seed Fund. He has more than 20 years' biotech and pharmaceutical industry experience, and within the last 10 years has held international executive positions in GlaxoSmithKline R&D before moving to take leadership of Crescendo Biologics. His industry and science experience covers most areas of drug discovery science and technology, and several therapeutic areas. During his career he has made significant contributions to GSK's drug development pipeline, and broadly to drug discovery strategy and technology.

 

Oron Assaf

Chief Business Officer
Biomx

Oron Assaf

Chief Business Officer
Biomx
 

Xavier Duportet

CEO
Eligo Biosciences

Xavier Duportet

CEO
Eligo Biosciences

The Agenda

Event Agenda

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Pitch Your Microbes

Central to MICROBIOME INVEST is ‘Pitch Your Microbes’, a platform for 12 of the most exciting emerging companies in microbiome to pitch their innovative ideas to a room full of potential advisors, investors and partners. Our esteemed selection committee will handpick these final
12 presenting companies from the list of all applicants.

To apply, you should meet one of the following entry criteria:

- An academic with a desire to develop and commercialise an innovative idea or piece of research that will benefit patients.
- A recent spin-out from an academic institution looking for financial investment, partnerships and advice.
- A biotech company at the pre-revenue or post-revenue stage, looking for financial investment, partnerships, licencing deals and advice.

CLICK HERE TO APPLY

DEADLINE: 6th APRIL 2018

Become a Sponsor

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and services, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with the conference will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. Build meaningful connections, showcase your brand and stay ahead of the competition.

Past sponsors include:

  • Raw materials, reagents, cell, antibodies providers
  • Equipment manufacturers
  • Process standardisation technology/services
  • Logistics companies
  • Contract research organisations
  • Contract manufacturing organisations

Media Partners

Resources

Download Resource

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

Academics, Biotech companies (under 3 years old), and Investors
£599 +VAT
Standard Pricing
Main Conference
One-to-One Meeting Scheduler
Post-Show Access to Presentations
Poster Sessions
Complimentary Articles and Content
Pharmaceutical, Nutrition & Biotech companies (over 3 years old)
£1,599 + VAT
Standard Pricing
Main Conference
One-to-One Meeting Scheduler
Post-Show Access to Presentations
Poster Sessions
Complimentary Articles and Content
Vendors (including Investment bankers, Lawyers, Consultants)
£1,899 + VAT
Standard Pricing
Main Conference
One-to-One Meeting Scheduler
Post-Show Access to Presentations
Poster Sessions
Complimentary Articles and Content
Poster Session (FREE for attendees (£50 for Non-Attendees)
£50 + VAT
Standard Pricing
Poster Session
Preparing registration...

Book a Team to Save More!

Industry Rates Only: Team discounts cannot be combined with any other discount or offer

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

 

Venue

Novotel London West, 1, Shortlands, W6 8DR, London

Room rate: £139 includes VAT and English breakfast. 

To book a room telephone reservations on + 44 (0) 208 741 1555  or

Email: [email protected]

Always quote:  KISACO220518

Book by 25 April 2018 

 

Contact Us

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.